Literature DB >> 19233325

Genomic response of hypoxic Müller cells involves the very low density lipoprotein receptor as part of an angiogenic network.

N Loewen1, J Chen, V J Dudley, V P Sarthy, J R Mathura.   

Abstract

Müller cells have recently been found to produce select angiogenic substances. In choosing a more comprehensive approach, we wanted to study the genomic response of Müller cells to hypoxia to identify novel angiogenic genes. An established Müller cell line (rMC-1) was exposed to standard or hypoxic conditions. We analyzed gene expression with three independent microarrays and determined differential expression levels compared to normoxia. Selected genes were confirmed by real-time PCR (RTPCR). Subcellular localization of proteins was examined by immunocytochemistry. A network-based pathway analysis was performed to investigate how those genes may contribute to angiogenesis. We found 19,004 of 28,000 known rat genes expressed in Müller cells. 211 genes were upregulated by hypoxia 1.5 to 14.9-fold (p<0.001, FDR<or=5%) and 220 genes were downregulated 1.5-4.6-fold (p<0.001, FDR<or=5%). Unexpectedly, expression patterns of cell proliferation, differentiation and organogenesis were increased besides predictable declines in cell function. Very low density lipoprotein receptor (VLDLR) and tribbles 3 (TRIB3) were further analyzed because of recent implication in retinal neovascularization and macular degeneration (VLDLR) and in ocular mesodermal development and differentiation (TRIB3), respectively. VLDLR was upregulated 3.1-fold (p=0.001, RTPCR 3.0-fold) and TRIB3 2.8-fold (p=0.025, RTPCR 5.1-fold). VEGF was increased 3.1-fold (p=0.003, RTPCR 8.3-fold) and apelin, a novel factor of retinal angiogenesis, 5.6-fold (p=0.006, RTPCR 8.7-fold). A network of interacting angiogenic genes was identified in silico that included VLDLR as a surface receptor. VLDLR protein localized to the perinucleus, cytoplasm and cell membrane, while TRIB3 was found in nucleoli, the nucleus and cytoplasm. We conclude that hypoxia triggers an angiogenic network response in Müller cells with VLDLR as a novel node and gene expression patterns of proliferation, differentiation and organogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233325     DOI: 10.1016/j.exer.2008.11.037

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  10 in total

1.  Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.

Authors:  Stephanie Debette; Sophie Visvikis-Siest; Ming-Huen Chen; Ndeye-Coumba Ndiaye; Ci Song; Anita Destefano; Radwan Safa; Mohsen Azimi Nezhad; Douglas Sawyer; Jean-Brice Marteau; Vanessa Xanthakis; Gerard Siest; Lisa Sullivan; Michele Pfister; Holly Smith; Seung-Hoan Choi; John Lamont; Lars Lind; Qiong Yang; Peter Fitzgerald; Erik Ingelsson; Ramachandran S Vasan; Sudha Seshadri
Journal:  Circ Res       Date:  2011-07-14       Impact factor: 17.367

2.  The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction.

Authors:  Jeanna C Perman; Pontus Boström; Malin Lindbom; Ulf Lidberg; Marcus StÅhlman; Daniel Hägg; Henrik Lindskog; Margareta Scharin Täng; Elmir Omerovic; Lillemor Mattsson Hultén; Anders Jeppsson; Petur Petursson; Johan Herlitz; Gunilla Olivecrona; Dudley K Strickland; Kim Ekroos; Sven-Olof Olofsson; Jan Borén
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

3.  Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.

Authors:  Saida Omarova; Casey D Charvet; Rachel E Reem; Natalia Mast; Wenchao Zheng; Suber Huang; Neal S Peachey; Irina A Pikuleva
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

4.  Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in disease.

Authors:  Howard M Prentice; Manas R Biswal; C Kathleen Dorey; Janet C Blanks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-01       Impact factor: 4.799

5.  Apelin is required for non-neovascular remodeling in the retina.

Authors:  Jenny A G McKenzie; Marcus Fruttiger; Sabu Abraham; Clemens A K Lange; Jay Stone; Pranita Gandhi; Xiaomeng Wang; James Bainbridge; Stephen E Moss; John Greenwood
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

6.  Analysis of candidate genes for macular telangiectasia type 2.

Authors:  Nancy L Parmalee; Carl Schubert; Joanna E Merriam; Kaija Allikmets; Alan C Bird; Mark C Gillies; Tunde Peto; Maria Figueroa; Martin Friedlander; Marcus Fruttiger; John Greenwood; Stephen E Moss; Lois E H Smith; Carmel Toomes; Chris F Inglehearn; Rando Allikmets
Journal:  Mol Vis       Date:  2010-12-14       Impact factor: 2.711

7.  Tribbles Homolog 3 Mediates the Development and Progression of Diabetic Retinopathy.

Authors:  Priyamvada M Pitale; Irina V Saltykova; Yvonne Adu-Agyeiwaah; Sergio Li Calzi; Takashi Satoh; Shizuo Akira; Oleg Gorbatyuk; Michael E Boulton; Machelle T Pardue; W Timothy Garvey; Mohammad Athar; Maria B Grant; Marina S Gorbatyuk
Journal:  Diabetes       Date:  2021-05-11       Impact factor: 9.337

8.  The role of apelin in the retina of diabetic rats.

Authors:  Qiang Lu; Jing Feng; Yan-Rong Jiang
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

9.  Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells.

Authors:  Katharina Leithner; Christoph Wohlkoenig; Elvira Stacher; Jörg Lindenmann; Nicole A Hofmann; Birgit Gallé; Christian Guelly; Franz Quehenberger; Philipp Stiegler; Freyja-Maria Smolle-Jüttner; Sjaak Philipsen; Helmut H Popper; Andelko Hrzenjak; Andrea Olschewski; Horst Olschewski
Journal:  BMC Cancer       Date:  2014-01-25       Impact factor: 4.430

10.  Tribbles expression in cumulus cells is related to oocyte maturation and fatty acid metabolism.

Authors:  Daphné Brisard; Franck Chesnel; Sébastien Elis; Alice Desmarchais; Laura Sánchez-Lazo; Manon Chasles; Virginie Maillard; Svetlana Uzbekova
Journal:  J Ovarian Res       Date:  2014-04-26       Impact factor: 4.234

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.